HEART LABS OF AMERICA INC /FL/
NT 10-Q, 1996-05-15
MEDICAL LABORATORIES
Previous: TELOR OPHTHALMIC PHARMACEUTICALS INC, 10-Q, 1996-05-15
Next: PREMIER FINANCIAL BANCORP INC, 10QSB, 1996-05-15



                     U.S. SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
 
                                   FORM 12b-25
                           Notification of Late Filing
 
                                                Commission File Number 0-20356
 
(CHECK ONE):    [  ] Form 10-K and Form 10-KSB               [  ] Form 11-K
[  ] Form 20-F  [X] Form 10-Q and Form 10-QSB                [  ] Form N-SAR
 
     For Period Ended:     MARCH 31, 1996
 
[  ] Transition Report on Form 10-K and Form 10-KSB
[  ] Transition Report on Form 20-F
[  ] Transition Report on Form 11-K
[  ] Transition Report on Form 10-Q and Form 10-QSB
[  ] Transition Report on Form N-SAR
 
     For the transition period Ended:
 
     Read Attached Instruction Sheet Before Preparing Form. Please Print or
Type.
 
     Nothing in this Form shall be construed to imply that the Commission has
verified any information contained herein.
 
     If the notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates:
 
                                    PART I
                            REGISTRANT INFORMATION
 
Full Name of Registrant:  HEART LABS OF AMERICA, INC.
Former Name if Applicable:
Address of Principal Executive Office (Street Number):
 
                      2650 N. MILITARY TRAIL, SUITE 230
 
City, State and Zip Code:  BOCA RATON, FLORIDA 33431
 
                                    PART II
                             RULE 12B-25(B) AND (C)
 
     If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check appropriate box.)
 
     [X] (a) The reasons described in reasonable detail in Part III of this
form could not be eliminated without unreasonable effort or expense;
 
     [ ] (b) The subject annual report or portion thereof will be filed on or
before the 15th calender day following the prescribed due date; or the subject
quarterly report or portion thereof will be filed on or before the fifth
calender day following the prescribed due date; and
 
     [ ] (c) The accountant's statement or other exhibit required by Rule
12b-25(c) has been attached if applicable.
 
                                    PART III
                                   NARRATIVE
 
     State below in reasonable detail the reasons why Forms 10K, 10-KSB, 11-K,
20-F, 10-Q, 10-QSB, N-SAR or the transition report or portion thereof could
not be filed within the prescribed time period. (Attach extra sheets if
needed.)
 
     As of the date of this Form 12b-25, the Company had not filed it's
10-KSB. An audit of a material acquisition made during the year had not been
completed and several other audit issues have yet to be resolved.
 
                                   PART IV
                              OTHER INFORMATION
 
     (1) Name and telephone number of person to contact in regard to this
notification:
 
Dawn M. Drella      (407)           241-7857
(Name)              (Area Code)     (Telephone Number)
 
(2) Have all other periodic reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months or for such
shorter period that the registrant was required to file such report(s) been
filed? If the answer is no, identify report(s):
 
[ ] Yes  [X] No
 
Form 8-K/A for the event of 8/23/95
 
Form 10-KSB for 1995
 
(3) Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be reflected by
the earnings statements to be included in the subject report or portion
thereof?
 
[ ] Yes  [X] No
 
If so: Attach an explanation of the anticipated change, both narratively and
quantitively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.
 
                         HEART LABS OF AMERICA, INC.
                 (Name of Registrant as specified in charter
 
Has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
 
Date: May 14, 1996
BY:  /s/ Dawn M. Drella
Dawn M. Drella
Chief Financial Officer


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission